Barinthus Biotherapeutics (BRNS)
1.03
0.06 (6.19%)
At close: Jan 15, 2025, 12:05 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -1.93 | 16.39 | -8.12 | -0.04 | n/a |
| PS Ratio | 176.62 | 1.96 | 1.54K | 0.14 | n/a |
| PB Ratio | 0.76 | 0.36 | 1.64 | -0.02 | n/a |
| P/FCF Ratio | -2.51 | -4.26 | -12.25 | -0.06 | n/a |
| P/OCF Ratio | -2.78 | -6.07 | -12.68 | -0.06 | n/a |
| OCF/S Ratio | -63.5 | -0.32 | -121.58 | -2.29 | -2.73 |
| Debt / Equity Ratio | 0.07 | 0.04 | 0.03 | -1.24 | -0.08 |
| Quick Ratio | 12.45 | 17.40 | 20.32 | 6.27 | 2.83 |
| Current Ratio | 12.45 | 17.40 | 20.32 | 6.27 | 2.83 |
| Asset Turnover | 0.00 | 0.17 | 0.00 | 0.10 | 0.36 |
| Interest Coverage | -3.00K | -212.68 | -16.95 | -5.57 | -193.33 |
| Return on Equity (ROE) | -0.39 | 0.02 | -0.2 | 0.47 | 0.93 |
| Return on Assets (ROA) | -0.34 | 0.02 | -0.18 | -0.35 | -1.09 |
| Return on Capital (ROIC) | -0.42 | -0.02 | -0.17 | -0.47 | -1.94 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Net Profit Margin | -9.15K% | 11.95% | -18.98K% | -367.27% | -302.84% |
| Pretax Profit Margin | -9.54K% | 1.90% | -19.08K% | -370.01% | -331.6% |
| Operating Profit Margin | -10.46K% | -9.04% | -16.87K% | -415.81% | -374.94% |
| FCF Margin | -7.02K% | -46.01% | -12.59K% | -234.83% | -274.8% |
| EBITDA Margin | -8.86K% | 14.33% | -17.86K% | -293.29% | -324.61% |